NeuroPace (NPCE) Free Cash Flow (2020 - 2026)
NeuroPace (NPCE) posted Free Cash Flow of -$4.0 million for Q2 2026, up 33.06% on a QoQ basis from -$6.0 million in Q1 2026, and down 86.14% year-over-year from -$29.1 million in Q2 2025.
Analysis
NeuroPace (NPCE) Free Cash Flow (2020 - 2026) Analysis & Trends
NeuroPace has reported Free Cash Flow for 7 years, with the latest figure at -$4.0 million in Q2 2026.
- On a quarterly basis, Free Cash Flow fell 86.14% year-over-year to -$4.0 million in Q2 2026; TTM through Jun 2026 was -$11.6 million, a 29.68% increase from a year earlier, with the FY2025 full-year figure at -$11.3 million, up 37.89% from the prior year.
- Free Cash Flow was -$4.0 million for Q2 2026 at NeuroPace, up from -$6.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $409000.0 in Q4 2025, with the low at -$11.7 million in Q1 2022.
- Average Free Cash Flow over 5 years is -$5.4 million, with a median of -$4.6 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow slumped 96.05% in 2022, then soared 108.54% in 2025.
- Over 5 years, Free Cash Flow stood at -$8.0 million in 2022, then jumped by 58.21% to -$3.3 million in 2023, then sank by 43.65% to -$4.8 million in 2024, then jumped by 108.54% to $409000.0 in 2025, then plunged by 1084.84% to -$4.0 million in 2026.
- The last three Free Cash Flow figures came in at -$4.0 million (Q2 2026), -$6.0 million (Q1 2026), and $409000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 948.40 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.06 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.28 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 585.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 606.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 184.50 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 279.60 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.03 Mn |
| Mar 31, 2026 | -6.02 Mn |
| Dec 31, 2025 | 409,000.00 |
| Sep 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -7.64 Mn |
| Dec 31, 2024 | -4.79 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -3.96 Mn |
| Mar 31, 2024 | -7.63 Mn |
| Dec 31, 2023 | -3.33 Mn |
| Sep 30, 2023 | -2.31 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -9.83 Mn |
| Dec 31, 2022 | -7.98 Mn |
| Sep 30, 2022 | -6.96 Mn |
| Jun 30, 2022 | -10.86 Mn |
| Mar 31, 2022 | -11.71 Mn |
| Dec 31, 2021 | -8.35 Mn |
| Sep 30, 2021 | -4.58 Mn |